Cross Country Healthcare sale to Knox Lane
We are advising Cross Country Healthcare on the transaction
Experience
To find Davis Polk deals and cases of particular interest, select filters based on practice, industry, region, lawyer and keyword.
Filters
Avalyn Pharma $300 million IPO
We advised the underwriters on the IPO
McKesson sale of minority stake in Medical-Surgical Solutions to Apollo
We are advising McKesson on the transaction
MiniMed $560 million IPO
The carve-out IPO of Medtronic’s diabetes unit is the second largest medtech IPO ever
One Call acquisition of Data Dimensions
We are advising One Call on the transaction
Coloplast acquisition of Uromedica
We are advising Coloplast on the transaction
AgomAb Therapeutics $200 million IPO
We advised the representatives of the several underwriters on the IPO
Eikon Therapeutics $381 million IPO
We advised the representatives of the several underwriters on the IPO
AbelZeta sale of China rights to GPC3 CAR-T therapy to AstraZeneca
We advised AbelZeta on the transaction
Penumbra $14.5 billion sale to Boston Scientific
We are advising Penumbra on the transaction